Funder
European Medicines Agency
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology,Toxicology
Reference21 articles.
1. Hooper DC. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis. 2001;32:S9-15. https://doi.org/10.1086/319370.
2. PRAC. Referral under Article 31 of Directive 2001/83/EC resulting from pharmacovigilance data—quinolone and fluoroquinolone medicinal products for systemic and inhalation use. In: PRAC Assessment Report; 2018. https://www.ema.europa.eu/en/documents/referral/quinolone-fluoroquinolone-article-31-referral-assessment-report_en.pdf. Accessed 19 Nov 2022.
3. Morales DR, Slattery J, Pacurariu A, Pinheiro L, McGettigan P, Kurz X. Relative and absolute risk of tendon rupture with fluoroquinolone and concomitant fluoroquinolone/corticosteroid therapy: population-based nested case–control study. Clin Drug Investig. 2019;39:205–13. https://doi.org/10.1007/s40261-018-0729-y.
4. Etminan M, Brophy JM, Samii A. Oral fluoroquinolone use and risk of peripheral neuropathy: a pharmacoepidemiologic study. Neurology. 2014;83(14):1261–3. https://doi.org/10.1212/WNL.0000000000000846.
5. Lee C-C, Lee MG, Chen Y-S, Lee S-H, Chen Y-S, Chen S-C, et al. Risk of aortic dissection and aortic aneurysm in patients taking oral fluoroquinolone. JAMA Intern Med. 2015;175:1839–47. https://doi.org/10.1001/jamainternmed.2015.5389.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献